Connect with us
The Spanish biotech company Pangaea Oncology is looking for funds to expand. The company has two main business areas. One is its care division, based on...
Pfizer closed the first quarter of 2022 with a profit of $7.86 billion, up from $4.88 billion collected between January and March 2021. The pharma developer...
Besins Healthcare's products include natural progesterone for pregnant women, transdermal gel for testosterone deficiency syndrome, and estradiol replacement therapies during menopause. Specifically, at the Muel plant,...
According to regulations, an accelerated authorization requires a confirmatory trial, so Pharma Mar announced in December 2021 the start of a confirmatory Phase III clinical trial,...
Grifols closed 2021 with a profit of $192 million (€182.3 million), compared with the $651 million (€618.5 million) recorded in 2020. Grifols recorded a turnover of...
Microviable Therapeutics emerged as a spin-off from Ipla-Csic in 2016, focused on the development of technologies and therapeutic products derived from the microbiota. Microviable Therapeutics will...
At the Madrid center, Peaches Biotech is developing a bio incubator focused on research and innovation (R&D) and aims to promote translational projects in the areas...
The president of Atrys Health gave a positive assessment of the 2021 financial year, in which the company launched the takeover bid for Aspy, various acquisitions...
In ten years since its inception, Moderna has transformed from a research-stage company advancing programs in the messenger RNA (mRNA) field to a company with a...
The Spanish biotech company AcceXible has recently entered the market in Colombia. AcceXible expects to have a turnover of $491,000 (€450,000) in 2022. The company received...
 |
|
 |  |
 |
|